OraSure Technologies Inc announced today that its OraQuick Hepatitis C (HCV) Rapid Antibody Test has been approved by the FDA for use in detecting HCV antibodies in venous whole blood specimens.
Read MoreCorgenix Medical Corp has been issued an additional US patent covering its AspirinWorks technology and product line.
Read MoreToday the United States Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB).
Read MorePGXL, a Louisville-based molecular diagnostics laboratory, announced a new contractual agreement with Generation Health (GH), making PGXL a preferred genetic testing lab for GH.
Read MoreHealth Diagnostic Laboratory Inc announced its new capability to run the CYP2C19 genetic test. HDL Inc, headquartered in the Virginia Biotechnology Research Park, has added CYP2C19 to its comprehensive panel of tests to help physicians better personalize treatment based on an expanded, total patient profile.
Read More